Effects of lovastatin and pravastatin on the survival of hamsters with inherited cardiomyopathy

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 5, Issue 4, 2000, Pages 275-279

  März, Winfried ^a   Siekmeier, Rüdiger ^b   Müller, Hans Michael ^a   Wieland, Heinrich ^a   Groß, Werner ^c   Olbrich, Hans Georg ^d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Federal Institute for Drugs and Medical Devices   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d Hospital St Elizabeth and St Barbara   (Germany)

Author keywords

Heart failure; Hmg coa reductase inhibitors; Hypercholesterolemia; Lovastatin; Pravastatin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; UBIQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HAMSTER; LIFESPAN; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

ADMINISTRATION, ORAL; ANIMALS; ANTICHOLESTEREMIC AGENTS; CARDIOMYOPATHIES; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; LOVASTATIN; MALE; PRAVASTATIN; SEX FACTORS; SURVIVAL ANALYSIS; UBIQUINONE;

EID: 0033759511     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1054/JCPT.2000.16695     Document Type: Article

References (31)

1. Regulation of the mevalonate pathway
2. ML-236A, ML-236B and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum
3. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits
4. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia
5. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
6. Lovastatin decreases coenzyme Q levels in rats
7. Lovastatin decreases coenzyme Q levels in humans
8. Influences of pravastatin and simvastatin, HMG-CoA reductase inhibitors, on myocardial stunning in dogs
9. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
10. Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat
11. Tissue-selective action of pravastatin due to hepatocellular uptake via a sodium-independent bile acid transporter
12. Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types
13. Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle
14. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
15. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
16. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
17. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
18. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
19. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys
20. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
21. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
22. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
23. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase
24. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by rho GTPase
25. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages
26. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types
27. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw 6228, and its inhibitory effect on vascular smooth muscle cell growth
28. Coenzyme Q10 attenuates the progression of cardiomyopathy in hamsters
29. Effect of a long-term treatment with lovastatin or fenofibrate on hepatic and cardiac ubiquinone levels in cardiomyopathic hamster
30. Dissociation of hepatic cholesterol synthesis from hepatic low-density lipoprotein uptake and biliary cholesterol saturation in female and male hamsters of different ages
31. Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat